By using a novel genetic approach, based on the properties of lambda cl repressor, we demonstrate that the HIV-1 Tat protein specifically interacts with the human p53 protein via the p53 O2 dimerization domain. By random and site-specific mutagenesis, we also identify the residues in Tat and O2 peptides which are involved in this interaction. Two alternative biological consequences are expected to result from Tat-p53 interaction: (i) Tat-O2 interaction inactivates p53 regulation function, thus producing cell transformation; (ii) Tat-O2 interaction favours the formation of p53 dimers, thus leading the cell towards apoptosis. (C) 1995 Academic Press, Inc.
Longo, F., Marchetti, M.a., Castagnoli, L., Battaglia, P.a., Gigliani, F. (1995). A novel approach to protein-protein interaction: Complex formation between the p53 tumor suppressor and the HIV Tat proteins. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 206(1), 326-334 [10.1006/bbrc.1995.1045].
A novel approach to protein-protein interaction: Complex formation between the p53 tumor suppressor and the HIV Tat proteins
CASTAGNOLI, LUISA;
1995-01-01
Abstract
By using a novel genetic approach, based on the properties of lambda cl repressor, we demonstrate that the HIV-1 Tat protein specifically interacts with the human p53 protein via the p53 O2 dimerization domain. By random and site-specific mutagenesis, we also identify the residues in Tat and O2 peptides which are involved in this interaction. Two alternative biological consequences are expected to result from Tat-p53 interaction: (i) Tat-O2 interaction inactivates p53 regulation function, thus producing cell transformation; (ii) Tat-O2 interaction favours the formation of p53 dimers, thus leading the cell towards apoptosis. (C) 1995 Academic Press, Inc.File | Dimensione | Formato | |
---|---|---|---|
Longo 1995.pdf
accesso aperto
Descrizione: Articolo principale
Dimensione
479.56 kB
Formato
Adobe PDF
|
479.56 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.